| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |